What Real Continuing Care Looks Like

What is aftercare, and why does it decide whether treatment holds?

Aftercare, or continuing care, is the plan for what happens once the most intensive phase of treatment ends. It matters because addiction behaves like a chronic condition rather than a one-time event: the Surgeon General's landmark report frames substance use disorder as a chronic brain disease that responds to sustained treatment and recovery support, not a problem cured by a single admission 1Ref 1U.S. Department of Health and Human Services, Office of the Surgeon General (2016).Facing Addiction in America: The Surgeon General's Report on Alcohol, Drugs, and Health.Frames substance use disorder as a chronic condition that responds to sustained treatment and recovery support rather than a single admission, the rationale for continuing care.. The evidence on duration is consistent. Federal guidance holds that remaining in treatment for an adequate time is critical, with outcomes generally improving the longer someone stays engaged, often ninety days or more across residential and outpatient care combined 2Ref 2National Institute on Drug Abuse (2018).Principles of Drug Addiction Treatment: A Research-Based Guide (Third Edition).Remaining in treatment for an adequate time is critical, with outcomes generally improving over roughly 90 days or more, and medically assisted detox alone is not treatment and rarely leads to lasting recovery.. The month after discharge, not the month inside, is usually when recovery is most fragile. A program that treats completion of a 28-day stay as the finish line has misread where the risk actually sits.

Continuing care is a step-down, not a discharge

Good continuing care lowers the intensity of support gradually instead of ending it abruptly. Addiction medicine describes a continuum of levels of care, from medically managed inpatient through residential, intensive outpatient, and standard outpatient, with placement matched to a person's assessed needs rather than a fixed package 3Ref 3American Society of Addiction Medicine (2024).The ASAM Criteria.Defines a standardized continuum of levels of care matched to assessed patient need, supporting that continuing care should step a person down through less intensive levels based on reassessment.. Understanding the ASAM levels of care helps you see what a step-down should look like in practice.

• Residential or inpatient provides the most structure, for the most acute needs.
• Partial hospitalization and intensive outpatient keep frequent contact while a person returns to daily life.
• Outpatient and recovery support maintain a lighter, longer connection.

The move between levels should follow a reassessment, not a calendar or an insurance limit. A plan that discharges someone from residential straight to nothing, with no next appointment scheduled, skips the part that carries recovery.

Medication belongs in continuing care and shouldn't be arbitrarily stopped

For opioid use disorder, medication is a core part of ongoing care, not a phase to graduate from on a schedule. The national practice guideline recommends treating opioid use disorder with methadone or buprenorphine rather than withdrawal management alone, holds that no medication should be withheld because someone is still using other substances, and states that medication should not be arbitrarily time-limited 4Ref 4American Society of Addiction Medicine (2020).The ASAM National Practice Guideline for the Treatment of Opioid Use Disorder — 2020 Focused Update.Recommends treating opioid use disorder with methadone or buprenorphine rather than withdrawal management alone, holds no medication should be withheld for ongoing use of other substances, and that medication should not be arbitrarily time-limited.. The guideline of record holds that medication for opioid use disorder should not be arbitrarily time-limited 4Ref 4American Society of Addiction Medicine (2020).The ASAM National Practice Guideline for the Treatment of Opioid Use Disorder — 2020 Focused Update.Recommends treating opioid use disorder with methadone or buprenorphine rather than withdrawal management alone, holds no medication should be withheld for ongoing use of other substances, and that medication should not be arbitrarily time-limited.. A continuing-care plan that pressures a person off their medication to prove progress, or that frames medication as failure, is working against the evidence. When you ask questions to ask a rehab about aftercare, one of the most revealing is whether medication continues after discharge and who prescribes it.

Detox alone is not continuing care

A common and costly misunderstanding is treating detoxification as the whole of treatment. Federal guidance is blunt: medically assisted withdrawal management alone is not treatment and rarely produces lasting recovery on its own 2Ref 2National Institute on Drug Abuse (2018).Principles of Drug Addiction Treatment: A Research-Based Guide (Third Edition).Remaining in treatment for an adequate time is critical, with outcomes generally improving over roughly 90 days or more, and medically assisted detox alone is not treatment and rarely leads to lasting recovery.. The reason detox is not treatment is that clearing a substance from the body addresses the acute physical crisis, not the condition that drives return to use. Continuing care is what turns a detox into the start of recovery instead of a revolving door. A program that offers a short medical detox and calls the job done, with no step-down and no plan for the months after, is selling the least durable part of care as if it were the whole thing. The question to ask is what happens on day 8, day 30, and day 90. A short detox with no answer to that question is not a treatment plan; it is a discharge waiting to become a readmission. The same caution applies to any program that markets a brief stay as complete care while leaving the durable, less profitable months entirely unplanned.

The behavioral and social supports that carry recovery

Beyond medication, real continuing care includes behavioral treatment and ongoing support, and the strongest of these are evidence-based, not improvised. Contingency management, which provides tangible incentives for verified progress, is among the most effective behavioral interventions and is especially important for stimulant use disorder, where no medication is FDA-approved 5Ref 5National Academies of Sciences, Engineering, and Medicine (2023).Contingency Management for the Treatment of Substance Use Disorders: Enhancing Access, Quality, and Program Integrity for an Evidence-Based Intervention.Contingency management is a strongly evidence-based behavioral treatment and among the most effective interventions for stimulant use disorder, for which no medication is FDA-approved.. A quality plan also connects a person to counseling, peer or mutual-help groups, and practical supports for housing and work, because recovery happens in a life, not a vacuum. What matters when you evaluate a program's aftercare is whether these supports are named, scheduled, and matched to the individual, or whether they are a vague promise of a weekly group with no structure behind it. Evidence-based treatment continues after the residential phase; it doesn't stop at the door. A useful test is specificity: a serious plan can tell you which group meets when, which clinician a person will see, and how progress is tracked. A plan that offers only encouragement to 'stay connected' has named a hope, not a structure, and hope is not a schedule.

What a real discharge plan looks like, and how to vet it

A real continuing-care plan is written down before discharge and answers concrete questions: which level of care comes next, when the first appointment is, who prescribes any medication and where, what the relapse-response plan is, and who to call at 2am. Ask to see it, and ask early, because a program that can describe its aftercare in specifics on day one usually has one, and a program that improvises it at discharge usually doesn't. Cost should not end the plan either. Federal block-grant funds are distributed to every state's substance-use agency to pay for community treatment and recovery services, which is the mechanism behind low- and no-cost continuing care for people without generous coverage 6Ref 6Substance Abuse and Mental Health Services Administration (2024).Substance Use Prevention, Treatment, and Recovery Services Block Grant (SUBG/SABG).Federal block-grant funds are distributed to every state's substance-use agency to fund community treatment and recovery services, the mechanism behind low- and no-cost continuing care.. A program that treats aftercare as an upsell, available only if you can pay more at the end, has inverted the priority: continuing care is the part most likely to protect the investment already made in the acute phase. Continuing care exists even when money is tight, and asking about state-funded options is a normal, reasonable question.